Utang jangka cendhak marang ekuitas serinatherapeutics.com (SER)

Serina Therapeutics, Inc. (SER) operates as a virtual biopharmaceutical business, outsourcing synthesis and testing to external contractors while maintaining full patent ownership. The development of Parkinson's disease treatments based on the POZ system opens prospects for partnerships with global leaders. This price chart reflects the 0.00 indicator. The company is currently implementing software robots and automated screening for the rapid processing of research data.

For the biotech sector, this indicator serves as a marker of the operational resilience of Serina Therapeutics, Inc. (SER) while funding the development of the POZ Polymer platform. By analyzing the current ratio of short-term loans to equity, investors assess the proportion of liabilities with maturities exceeding one year relative to equity, confirming the company's ability to maintain strong pricing power and patent protection without a critical debt load.